Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer

被引：0
|
作者：
Elin Trägårdh
David Minarik
Gustav Brolin
Ulrika Bitzén
Berit Olsson
Jenny Oddstig
机构：
[1] Skåne University Hospital and Lund University,Clinical Physiology and Nuclear Medicine
[2] Lund University,Wallenberg Centre for Molecular Medicine
[3] Skåne University and Lund University,Medical Radiation Physics
[4] Skåne University Hospital and Lund University,Medical Radiation Physics
[5] Skåne University and Lund University,Clinical Physiology and Nuclear Medicine
来源：
EJNMMI Physics | / 7卷
关键词：
PET-CT; PSMA; Block-sequential regularized expectation maximization; Q.Clear; Image quality; [18F]PSMA-1007;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
    Tragardh, Elin
    Minarik, David
    Brolin, Gustav
    Bitzen, Ulrika
    Olsson, Bent
    Oddstig, Jenny
    EJNMMI PHYSICS, 2020, 7 (01)
  • [2] Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
    Clemens Mingels
    Karl Peter Bohn
    Axel Rominger
    Ali Afshar-Oromieh
    Ian Alberts
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 2436 - 2444
  • [3] Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT
    Giesel, Frederik L.
    Will, Leon
    Kesch, Claudia
    Freitag, Martin
    Kremer, Christophe
    Merkle, Jonas
    Neels, Oliver C.
    Cardinale, Jens
    Hadaschik, Boris
    Hohenfellner, Markus
    Kopka, Klaus
    Haberkorn, Uwe
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 632 - 635
  • [4] Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
    Mingels, Clemens
    Bohn, Karl Peter
    Rominger, Axel
    Afshar-Oromieh, Ali
    Alberts, Ian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (07) : 2436 - 2444
  • [5] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Chikatamarla, Venkata Avinash
    Okano, Satomi
    Jenvey, Peter
    Ansaldo, Alexander
    Roberts, Matthew J.
    Ramsay, Stuart C.
    Thomas, Paul A.
    Pattison, David A.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [6] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Venkata Avinash Chikatamarla
    Satomi Okano
    Peter Jenvey
    Alexander Ansaldo
    Matthew J. Roberts
    Stuart C. Ramsay
    Paul A. Thomas
    David A. Pattison
    EJNMMI Research, 11
  • [7] [18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
    Cato C. Loeff
    Willemijn van Gemert
    Bastiaan M. Privé
    Inge M. van Oort
    Rick Hermsen
    Diederik M. Somford
    James Nagarajah
    Linda Heijmen
    Marcel J. R. Janssen
    EJNMMI Reports, 8 (1)
  • [8] Role of volumetric parameters on [18F]PSMA-1007 PET/CT in primary staging of prostate cancer
    Castello, A.
    Farulla, L. Airo
    Longari, V.
    Orunesu, E.
    Schiavini, M.
    Bardo, F.
    Arnaboldi, M.
    Galli, E.
    Florimonte, L.
    Castellani, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S488 - S488
  • [9] Diagnostic accuracy of [18F]-PSMA-1007 PET/CT in biochemical recurrent prostate cancer patients - a retrospective analysis
    Mingels, C.
    Hunermund, J.
    Bohn, K. P.
    Rominger, A.
    Afshar-Oromieh, A.
    Alberts, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S447 - S447
  • [10] Molecular Imaging of Prostate Cancer: A direct comparison of the preclinical characteristics of [18F] DCFPyL and [18F]PSMA-1007 and the impact of glutamic acids on [18F]PSMA-1007
    Roscher, M.
    Remde, Y.
    Schaefer, M.
    Bauder-Wuest, U.
    Giesel, F.
    Neels, O. C.
    Cardinale, J.
    Kopka, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S54 - S55
12345